Citadel Advisors - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 139 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,458,000
+401.2%
228,542
+148.5%
0.00%
Q2 2022$690,000
-18.2%
91,957
-0.8%
0.00%
Q1 2022$844,000
+157.3%
92,732
+98.2%
0.00%
Q4 2021$328,000
-96.0%
46,781
-93.5%
0.00%
-100.0%
Q3 2021$8,177,000
+454.4%
717,281
+678.5%
0.00%
Q2 2021$1,475,000
-22.5%
92,135
-13.5%
0.00%
Q1 2021$1,904,000
-67.9%
106,540
-75.7%
0.00%
-100.0%
Q4 2020$5,928,000
-46.4%
438,755
-53.4%
0.00%
-66.7%
Q3 2020$11,070,000
-56.6%
940,530
-45.5%
0.00%
-66.7%
Q2 2020$25,487,000
+371.3%
1,726,775
+331.0%
0.01%
+350.0%
Q1 2020$5,408,000
-76.5%
400,637
-57.9%
0.00%
-80.0%
Q4 2019$22,991,000
+147.0%
951,192
+96.4%
0.01%
+100.0%
Q3 2019$9,307,000
+80.2%
484,271
+177.0%
0.01%
+150.0%
Q2 2019$5,165,000
-73.6%
174,801
-57.5%
0.00%
-81.8%
Q1 2019$19,540,000
-66.2%
411,360
-74.3%
0.01%
-64.5%
Q4 2018$57,855,000
-36.0%
1,602,630
+9.1%
0.03%
-24.4%
Q3 2018$90,407,000
+2620.6%
1,468,829
+2885.2%
0.04%
+1950.0%
Q2 2018$3,323,000
+92.2%
49,204
+54.4%
0.00%
Q1 2018$1,729,000
-63.0%
31,861
-59.3%
0.00%
-100.0%
Q4 2017$4,672,000
-65.2%
78,203
-71.7%
0.00%
-72.7%
Q3 2017$13,435,000
+56.3%
276,421
+69.0%
0.01%
+57.1%
Q2 2017$8,595,000
-56.7%
163,559
-62.7%
0.01%
-61.1%
Q1 2017$19,872,000
-54.1%
438,189
-61.7%
0.02%
-58.1%
Q4 2016$43,255,000
+79.3%
1,142,795
+78.8%
0.04%
+79.2%
Q3 2016$24,123,000
+15265.0%
639,154
+4848.2%
0.02%
Q1 2016$157,000
-28.6%
12,917
+4.1%
0.00%
Q3 2015$220,000
+155.8%
12,403
+155.7%
0.00%
Q2 2015$86,0004,8510.00%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders